Regional Green Light Committee for the WHO European Region workshop and face-to-face meeting: Introduction of new medicines for the treatment of drug-resistant tuberculosis in the WHO European Region (2017)

The regional Green Light Committee for the WHO European Region (rGLC/Europe) conducted a workshop on the “Introduction of new medicines for the treatment of drug-resistant tuberculosis in the WHO European Region” on 25–26 July 2017, followed by a meeting on 27 July, in Copenhagen, Denmark.

The overall objectives of the 3 days were to exchange experiences and update rGLC/Europe members and consultants on the introduction of new drugs, new treatment regimens and current WHO global and regional policies and initiatives.

One of the key outcomes of the sessions was a set of recommendations for action put forward to WHO and partners.